January 19, 2022Open Access

Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The growth of AI techniques in health care opened a broad gate for discovering the genomic sequences of the COVID-19 virus and the VOC. AI helps also in the development of vaccines and drugs (including drug repurposing) to obtain potential preventive and therapeutic agents for controlling the COVID-19 pandemic.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Bagabir et al. (Wed,) studied this question.

synapsesocial.com/papers/69dcc9f91e43378fbd13359b https://doi.org/https://doi.org/10.1016/j.jiph.2022.01.011

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Design of a Multiepitope‐Based Peptide Vaccine against the E Protein of Human COVID‐19: An Immunoinformatics Approach2020 · 217 citations
2Artificial intelligence in drug discovery and development2020 · 1,570 citations
3Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov2020 · 178 citations
4Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection2020 · 196 citations
5SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis2021 · 152 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo